Zobrazeno 1 - 10
of 32
pro vyhledávání: '"G. Caleb Alexander"'
Autor:
Brian T. Garibaldi, Christopher G. Chute, Corey Joseph, Hemalkumar B. Mehta, Kathleen M Andersen, Richard A. Moffitt, Soko Setoguchi, Omar Mansour, Emaan S Rashidi, Benjamin Bates, Paul T Kocis, Huijun An, Tellen D. Bennett, Vithal Madhira, G. Caleb Alexander
Publikováno v:
Annals of Internal Medicine. 174:1395-1403
BACKGROUND: Relatively little is known about the use patterns of potential pharmacologic treatments of COVID-19 in the United States. OBJECTIVE: To use the National COVID Cohort Collaborative (N3C), a large, multicenter, longitudinal cohort, to chara
Publikováno v:
Neurology. 97:e1266-e1275
Background and ObjectivesTo determine the risk of hospitalization and death associated with pimavanserin use.MethodsWe conducted a retrospective cohort study of adults 65 years and older with Parkinson disease between November 1, 2015, and December 3
Autor:
G. Caleb Alexander, Jenny S. Guadamuz, Ben Urick, Dima M. Qato, Sun Choi, Carter D. McCormick
Publikováno v:
Journal of the American Pharmacists Association. 61:e100-e113
Telepharmacies, which dispense medications on-site under the supervision of an off-site pharmacist using telecommunication technologies, have been proposed as a means to ameliorate the impact of pharmacy closures and improve access to medications.To
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Clinical and Translational Science, Vol 14, Iss 1, Pp 153-162 (2021)
Many academic institutions are collecting blood samples from patients seeking treatment for coronavirus disease 2019 (COVID‐19) to build research biorepositories. It may be feasible to extract pharmacogenomic (PGx) information from biorepositories
Publikováno v:
Medical Care. 57:667-672
BACKGROUND Although buprenorphine is an evidence-based treatment for opioid use disorder (OUD), it is unknown whether buprenorphine use may affect patients' adherence to treatments for chronic, unrelated conditions. OBJECTIVES To quantify the effect
Autor:
Hemalkumar B. Mehta, Brian T. Garibaldi, Melissa A. Haendel, Jing Sun, Amy L. Olex, Christopher G. Chute, Rena C Patel, Jasvinder A. Singh, Paul G. Auwaerter, Emaan S Rashidi, Roslyn B. Mannon, Derek K. Ng, Kathleen M Andersen, Jodi B Segal, G. Caleb Alexander, Benjamin Bates
Publikováno v:
The Lancet. Rheumatology
Summary Background Many individuals take long-term immunosuppressive medications. We evaluated whether these individuals have worse outcomes when hospitalised with COVID-19 compared with non-immunosuppressed individuals. Methods We conducted a retros
Autor:
Jiajun Wen, Jodi B Segal, Hsien Yen Chang, G. Caleb Alexander, Omar Mansour, Mara McAdams-DeMarco, Sheriza N. Baksh, Stephan Ehrhardt
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Clinical trials investigating cardiovascular safety of dipeptidyl peptidase-IV inhibitors (DPP-4i) among patients with cardiovascular and renal disease rarely recruit patients with renal impairment, despite associations with increased risk for major
Autor:
G. Caleb Alexander, Jessica Y Islam, Nora Franceschini, Teresa Po-Yu Chiang, Jing Sun, Roslyn B. Mannon, Richard A. Moffitt, Christopher G. Chute, Rena C Patel, Kathleen M Andersen, Keith A. Crandall, Amanda J. Vinson, Evan French, Amy L. Olex, Qulu Zheng, Todd T. Brown, Vithal Madhira, Gregory D. Kirk, Hana Akselrod
Publikováno v:
medRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
BackgroundIndividuals with immune dysfunction, including people with HIV (PWH) or solid organ transplant recipients (SOT), might have worse outcomes from COVID-19. We compared odds of COVID-19 outcomes between patients with and without immune dysfunc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36324dd2e2445954d6297c5ddfef2dae
https://doi.org/10.1101/2021.07.26.21261028
https://doi.org/10.1101/2021.07.26.21261028
Autor:
Xinci Chen, Brian T. Garibaldi, Ruhul Abid, Thomas R. O'Brien, G. Caleb Alexander, Paul T Kocis, Vithal Madhira, Rosa Ergas, Sam Bozzette, Soko Setoguchi, Joy Alamgir, Masanao Yajima, Hemalkumar B. Mehta, Naved Munir, Stephanie S Hong
BackgroundEffects of timing of Convalescent plasma (CP) administration on hospitalized COVID-19 patients are not established.MethodsWe used the National COVID Cohort Collaborative data to perform a retrospective cohort study of hospitalized COVID-19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06cff80d1b9d4163bc1cc6070ac3fc9a
https://doi.org/10.1101/2021.05.04.21256627
https://doi.org/10.1101/2021.05.04.21256627
Autor:
Brendan Saloner, Kelly E. Anderson, Julia Eckstein, G. Caleb Alexander, Sydney M. Dy, Lauren Niles, Sarah Hudson Scholle, Christine E. Chaisson
Publikováno v:
Med Care
AIMS: To characterize quality of buprenorphine care for opioid use disorder by quantifying buprenorphine initiation, engagement, and maintenance for individuals in a large, diverse, real-world cohort in the United States. DESIGN: Retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57eb2bbe06f39bc0ac13b88166fc687
https://europepmc.org/articles/PMC8026663/
https://europepmc.org/articles/PMC8026663/